Garden City
Listen to The Optimal Health Program for latest on Stem Cell Therapy Treatments
Click Here for Telemedicine Consultation & Appointment

Daily Archives for: July 16th, 2007

Background Crohn`s disease is a chronic inflammatory disorder of the bowel. In a preliminary study, we evaluated whether the administration of growth hormone (somatropin) as well as a high-protein diet would ameliorate the symptoms of the disease.

Methods We randomly assigned 37 adults with moderate-to-severe active Crohn`s disease to four months of self-administered injections of growth hormone (loading dose,

The effects of recombinant GH doses (10 micrograms/kg.day, 3 times a week for 6 months) lower than those previously used in the results of GH-deficient adults (GHDA) on body composition, bone mineral content, and heart structure and function were investigated in seven (six males and one female, aged 25-27 yr) GHDA. They were studied before results,

During the past two decades, the prevalence of obesity in children has risen greatly worldwide. Obesity in childhood causes a wide range of serious complications, and increases the risk of premature illness and death later in life, raising public-health concerns.

Results of research have provided new insights into the physiological basis of bodyweight regulation.

Breastfeeding might confer protection against obesity later in life, but the evidence is inconclusive. We tested the hypothesis that breastfeeding is associated with a reduced risk of obesity in a population-based sample of 32 200 Scottish children studied at age 39–42 months in 1998 and 1999.

Obesity was defined as body-mass index (BMI) at the 95th and 98th percentiles or higher.

Levels of iron, copper, zinc, manganese, and lead were measured by inductively coupled plasma spectroscopy in parkinsonian and age-matched control brain tissue. There was 31-35% increase in the total iron content of the parkinsonian substantia nigra when compared to control tissue. In contrast, in the globus pallidus total iron levels were decreased by 29% in Parkinson's disease.